Journal of Shanghai Jiao Tong University (Medical Science) ›› 2023, Vol. 43 ›› Issue (2): 256-260.doi: 10.3969/j.issn.1674-8115.2023.02.017
• Review • Previous Articles
FENG Jiali1,2,3(), PENG Yu3,4, DUAN Junkai1,3()
Received:
2022-08-22
Accepted:
2023-01-15
Online:
2023-02-28
Published:
2023-02-28
Contact:
DUAN Junkai
E-mail:316240143@qq.com;yeduanjk@163.com
Supported by:
CLC Number:
FENG Jiali, PENG Yu, DUAN Junkai. Progress in functional mechanisms and biomarkers of miRNA related to Kawasaki disease[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(2): 256-260.
Add to citation manager EndNote|Ris|BibTeX
URL: https://xuebao.shsmu.edu.cn/EN/10.3969/j.issn.1674-8115.2023.02.017
1 | 孙锟, 沈颖, 黄国英. 小儿内科学[M]. 6版. 北京: 人民卫生出版社, 2020: 303. |
SUN K,SHEN Y,HUANG G Y.Pediatric Internal Medicine[M].Beijing: People's Medical Publishing House, 2020: 303. | |
2 | KIM G B, PARK S, EUN L Y, et al. Epidemiology and clinical features of Kawasaki disease in south Korea, 2012‒2014[J]. Pediatr Infect Dis J, 2017, 36(5): 482-485. |
3 | LEONG K, KANE J M, JOY B F. Acquired cardiac disease in the pediatric intensive care unit[J]. Pediatr Ann, 2018, 47(7): e280-e285. |
4 | SHUKLA G C, SINGH J, BARIK S. MicroRNAs: processing, maturation, target recognition and regulatory functions[J]. Mol Cell Pharmacol, 2011, 3(3): 83-92. |
5 | HA M J, KIM V N. Regulation of microRNA biogenesis[J]. Nat Rev Mol Cell Biol, 2014, 15(8): 509-524. |
6 | KINSER H E, PINCUS Z. MicroRNAs as modulators of longevity and the aging process[J]. Hum Genet, 2020, 139(3): 291-308. |
7 | SALIMINEJAD K, KHORRAM KHORSHID H R, SOLEYMANI FARD S, et al. An overview of microRNAs: biology, functions, therapeutics, and analysis methods[J]. J Cell Physiol, 2019, 234(5): 5451-5465. |
8 | CORTEZ M A, CALIN G A. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases[J]. Expert Opin Biol Ther, 2009, 9(6): 703-711. |
9 | CHEN X, BA Y, MA L J, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases[J]. Cell Res, 2008, 18(10): 997-1006. |
10 | LIAO C, YIN A H, PENG C F, et al. Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing[J]. Proc Natl Acad Sci USA, 2014, 111(20): 7415-7420. |
11 | 范雪, 徐明国. 川崎病发病机制及治疗研究进展[J]. 中国实用儿科杂志, 2021, 36(5): 339-344. |
FAN X,XU M G.Research progress in the pathogenesis and treatment of Kawasaki disease[J].Chinese Journal of Practical Pediatrics,2021,36(5):339-344. | |
12 | NI F F, LI C R, LI Q, et al. Regulatory T cell microRNA expression changes in children with acute Kawasaki disease[J]. Clin Exp Immunol, 2014, 178(2): 384-393. |
13 | LUO Y, YANG J, ZHANG C, et al. Up-regulation of miR-27a promotes monocyte-mediated inflammatory responses in Kawasaki disease by inhibiting function of B10 cells[J]. J Leukoc Biol, 2020, 107(1): 133-144. |
14 | LI Z Y, JIANG J, TIAN L, et al. A plasma miR-125a-5p as a novel biomarker for Kawasaki disease and induces apoptosis in HUVECs[J]. PLoS One, 2017, 12(5): e0175407. |
15 | LIU C W, YANG D G, WANG H, et al. MicroRNA-197-3p mediates damage to human coronary artery endothelial cells via targeting TIMP3 in Kawasaki disease[J]. Mol Cell Biochem, 2021, 476(12): 4245-4263. |
16 | NAKAOKA H, HIRONO K, YAMAMOTO S, et al. MicroRNA-145-5p and microRNA-320a encapsulated in endothelial microparticles contribute to the progression of vasculitis in acute Kawasaki disease[J]. Sci Rep, 2018, 8(1): 1016. |
17 | CHU M P, WU R Z, QIN S S, et al. Bone marrow-derived microRNA-223 works as an endocrine genetic signal in vascular endothelial cells and participates in vascular injury from Kawasaki disease[J]. J Am Heart Assoc, 2017, 6(2): e004878. |
18 | ZHANG Y, WANG Y F, ZHANG L, et al. Reduced platelet miR-223 induction in Kawasaki disease leads to severe coronary artery pathology through a miR-223/PDGFRβ vascular smooth muscle cell axis[J]. Circ Res, 2020, 127(7): 855-873. |
19 | HE M, CHEN Z, MARTIN M, et al. MiR-483 targeting of CTGF suppresses endothelial-to-mesenchymal transition: therapeutic implications in Kawasaki disease[J]. Circ Res, 2017, 120(2): 354-365. |
20 | RONG X, GE D H, SHEN D P, et al. MiR-27b suppresses endothelial cell proliferation and migration by targeting Smad7 in Kawasaki disease[J]. Cell Physiol Biochem, 2018, 48(4): 1804-1814. |
21 | GORELIK M, CHUNG S A, ARDALAN K, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of Kawasaki disease[J]. Arthritis Rheumatol, 2022, 74(4): 586-596. |
22 | RIZK S R Y, EL SAID G, DANIELS L B, et al. Acute myocardial ischemia in adults secondary to missed Kawasaki disease in childhood[J]. Am J Cardiol, 2015, 115(4): 423-427. |
23 | WU R Z, SHEN D P, SOHUN H, et al. miR‑186, a serum microRNA, induces endothelial cell apoptosis by targeting SMAD6 in Kawasaki disease[J]. Int J Mol Med, 2018, 41(4): 1899-1908. |
24 | ZHANG X F, XIN G D, SUN D J. Serum exosomal miR-328, miR-575, miR-134 and miR-671-5p as potential biomarkers for the diagnosis of Kawasaki disease and the prediction of therapeutic outcomes of intravenous immunoglobulin therapy[J]. Exp Ther Med, 2018, 16(3): 2420-2432. |
25 | LV H F, SUN X Q, ZHOU H X, et al. Diagnostic value of miRNA-122 in Kawasaki disease[J]. Eur Rev Med Pharmacol Sci, 2020, 24(21): 11222-11226. |
26 | NING Q Q, CHEN L Q, SONG S R, et al. The platelet microRNA profile of Kawasaki disease: identification of novel diagnostic biomarkers[J]. Biomed Res Int, 2020, 2020: 9061568. |
27 | WENG K P, CHENG C F, CHIEN K J, et al. Identifying circulating microRNA in Kawasaki disease by next-generation sequencing approach[J]. Curr Issues Mol Biol, 2021, 43(2): 485-500. |
28 | YAN J, WANG H, GAO L X. Diagnostic value of serum miR-1 in patients with acute Kawasaki disease[J]. Clin Lab, 2019, 65(7). DOI:10.7754/Clin.Lab.2019.190339. |
29 | SAITO K, NAKAOKA H, TAKASAKI I, et al. MicroRNA-93 may control vascular endothelial growth factor A in circulating peripheral blood mononuclear cells in acute Kawasaki disease[J]. Pediatr Res, 2016, 80(3): 425-432. |
30 | SHIMIZU C, KIM J, STEPANOWSKY P, et al. Differential expression of miR-145 in children with Kawasaki disease[J]. PLoS One, 2013, 8(3): e58159. |
31 | ZHANG R, WU L, ZHANG H J, et al. Expression levels of plasma miRNA-21 and NT-proBNP in children with Kawasaki disease and their clinical significance[J]. Eur Rev Med Pharmacol Sci, 2020, 24(24): 12757-12762. |
32 | ZHENG X L, LI Y F, YUE P, et al. Diagnostic significance of circulating miRNAs in Kawasaki disease in China: current evidence based on a meta-analysis[J]. Medicine, 2021, 100(6): e24174. |
33 | JIA H L, LIU C W, ZHANG L, et al. Sets of serum exosomal microRNAs as candidate diagnostic biomarkers for Kawasaki disease[J]. Sci Rep, 2017, 7: 44706. |
34 | KIBATA T, SUZUKI Y, HASEGAWA S, et al. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin[J]. Int J Cardiol, 2016, 214: 209-215. |
35 | LI X, CHEN Y, TANG Y J, et al. Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases[J]. Eur J Pediatr, 2018, 177(8): 1279-1292. |
36 | ZHANG W, WANG Y, ZENG Y W, et al. Serum miR-200c and miR-371-5p as the useful diagnostic biomarkers and therapeutic targets in Kawasaki disease[J]. Biomed Res Int, 2017, 2017: 8257862. |
37 | RONG X, JIA L H, HONG L L, et al. Serum miR-92a-3p as a new potential biomarker for diagnosis of Kawasaki disease with coronary artery lesions[J]. J of Cardiovasc Trans Res, 2017, 10(1): 1-8. |
38 | LI S C, HUANG L H, CHIEN K J, et al. MiR-182-5p enhances in vitro neutrophil infiltration in Kawasaki disease[J]. Mol Genet Genomic Med, 2019, 7(12): e990. |
39 | WANG Y F, LIAN X L, ZHONG J Y, et al. Serum exosomal microRNA let-7i-3p as candidate diagnostic biomarker for Kawasaki disease patients with coronary artery aneurysm[J]. IUBMB Life, 2019, 71(7): 891-900. |
40 | WANG Y F, LU Z L, FU L Y, et al. The miRNA-608 rs4919510 G>C polymorphism confers reduce coronary injury of Kawasaki disease in a southern Chinese population[J]. Biosci Rep, 2019, 39(5): BSR20181660. |
41 | FU L Y, XU Y F, YU H Y, et al. Association study of miR-149, miR-196a2, and miR-499a polymorphisms with coronary artery aneurysm of Kawasaki disease in southern Chinese population[J]. J Gene Med, 2022, 24(4): e3405. |
[1] | HOU Shumin, SHAO Jingbo. Research progress in clinical characteristics, diagnosis and prognosis of TdT-negative lymphoblastic lymphoma/acute lymphoblastic leukemia [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(1): 120-124. |
[2] | JIANG Wenqun, HOU Pinpin, CHEN Yan, JIA Feng, ZHANG Xiaohua, GAO Li, HU Qin. Characteristics and clinical significance of serum renalase in patients with acute ischemic stroke [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(1): 29-35. |
[3] | HUANG Zhiwu, WU Hao. Research progress and clinical intervention strategy of age-related hearing loss [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(9): 1182-1187. |
[4] | ZHANG Lincheng, ZHONG Hua. Progress in pathogenesis and clinical treatment of sarcoidosis [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(7): 931-938. |
[5] | HE Dongmei, YANG Chi. Diagnosis and treatment protocol of mandibular condylar fracture: experience from the TMJ Center of Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(6): 695-701. |
[6] | HE Dongmei, YANG Chi. Diagnosis and treatment protocol of temporomandibular joint (TMJ) ankylosis: experience from the TMJ Center of Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(6): 702-708. |
[7] | ZHANG Shanyong, YANG Chi. Protocols for diagnosis and treatment of temporomandibular joint osteoarthritis: experience from the TMJ Center of Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(6): 709-716. |
[8] | LÜ Yongfen, LI Pin. Molecular diagnosis and clinical significance of 21-hydroxylase deficiency [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(5): 557-561. |
[9] | CHEN Yiting, ZHAO Anda, LI Rong, KANG Wenhui, LI Shenghui. Review of the role of circulating exosomal microRNA in bronchial asthma [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(3): 375-380. |
[10] | ZHAO Jiuhong, TONG Jiating, SHEN Zhijun, LÜ Yehui. Research progress in the mechanism of interactive regulation between circular RNA and oxidative stress [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(3): 393-399. |
[11] | Yihua ZOU, Jie PENG, Peiquan ZHAO. Review of clinical features and treatment of congenital cavitary optic disc anomalies [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2022, 42(2): 230-234. |
[12] | GU Shuneng, WU Pengfei, WU Yurong. Diagnosis and treatment of congenital vascular ring: prenatal and postnatal [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(11): 1620-1626. |
[13] | LI Min, WU Yi, CHENG Weiwei. Status and prospect of prenatal genetic diagnosis of fetal congenital heart disease [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(10): 1498-1503. |
[14] | Li LIU, Zi-long GENG, Jia-huan CHEN, Sha-sha ZHANG, Bing ZHANG. Whole gene expression profile analysis of miRNAs in human umbilical vein endothelial cells regulated by vascular endothelial growth factor A [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(9): 1183-1189. |
[15] | Lei XIONG, Qian YI, Ming-fang XU, Jian CHEN. Expression and prognosis analysis of MRPL12 in lung adenocarcinoma [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(8): 1033-1040. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||